1 Vascular Biosynthetic Grafts Market Overview 1.1 Product Overview and Scope of Vascular Biosynthetic Grafts 1.2 Vascular Biosynthetic Grafts Segment by Type 1.2.1 Global Vascular Biosynthetic Grafts Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Endovascular Aneurysm Repair 1.2.3 Peripheral Vascular 1.2.4 Hemodialysis Access 1.3 Vascular Biosynthetic Grafts Segment by Application 1.3.1 Vascular Biosynthetic Grafts Sales Comparison by Application: (2021-2027) 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.4 Global Vascular Biosynthetic Grafts Market Size Estimates and Forecasts 1.4.1 Global Vascular Biosynthetic Grafts Revenue 2016-2027 1.4.2 Global Vascular Biosynthetic Grafts Sales 2016-2027 1.4.3 Vascular Biosynthetic Grafts Market Size by Region: 2016 Versus 2021 Versus 2027 2 Vascular Biosynthetic Grafts Market Competition by Manufacturers 2.1 Global Vascular Biosynthetic Grafts Sales Market Share by Manufacturers (2016-2021) 2.2 Global Vascular Biosynthetic Grafts Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Vascular Biosynthetic Grafts Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Vascular Biosynthetic Grafts Manufacturing Sites, Area Served, Product Type 2.5 Vascular Biosynthetic Grafts Market Competitive Situation and Trends 2.5.1 Vascular Biosynthetic Grafts Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Vascular Biosynthetic Grafts Players Market Share by Revenue 2.5.3 Global Vascular Biosynthetic Grafts Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Vascular Biosynthetic Grafts Retrospective Market Scenario by Region 3.1 Global Vascular Biosynthetic Grafts Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Vascular Biosynthetic Grafts Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Vascular Biosynthetic Grafts Market Facts & Figures by Country 3.3.1 North America Vascular Biosynthetic Grafts Sales by Country 3.3.2 North America Vascular Biosynthetic Grafts Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Vascular Biosynthetic Grafts Market Facts & Figures by Country 3.4.1 Europe Vascular Biosynthetic Grafts Sales by Country 3.4.2 Europe Vascular Biosynthetic Grafts Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Vascular Biosynthetic Grafts Market Facts & Figures by Region 3.5.1 Asia Pacific Vascular Biosynthetic Grafts Sales by Region 3.5.2 Asia Pacific Vascular Biosynthetic Grafts Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Vascular Biosynthetic Grafts Market Facts & Figures by Country 3.6.1 Latin America Vascular Biosynthetic Grafts Sales by Country 3.6.2 Latin America Vascular Biosynthetic Grafts Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Vascular Biosynthetic Grafts Market Facts & Figures by Country 3.7.1 Middle East and Africa Vascular Biosynthetic Grafts Sales by Country 3.7.2 Middle East and Africa Vascular Biosynthetic Grafts Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Vascular Biosynthetic Grafts Historic Market Analysis by Type 4.1 Global Vascular Biosynthetic Grafts Sales Market Share by Type (2016-2021) 4.2 Global Vascular Biosynthetic Grafts Revenue Market Share by Type (2016-2021) 4.3 Global Vascular Biosynthetic Grafts Price by Type (2016-2021) 5 Global Vascular Biosynthetic Grafts Historic Market Analysis by Application 5.1 Global Vascular Biosynthetic Grafts Sales Market Share by Application (2016-2021) 5.2 Global Vascular Biosynthetic Grafts Revenue Market Share by Application (2016-2021) 5.3 Global Vascular Biosynthetic Grafts Price by Application (2016-2021) 6 Key Companies Profiled 6.1 B. Braun (Germany) 6.1.1 B. Braun (Germany) Corporation Information 6.1.2 B. Braun (Germany) Description and Business Overview 6.1.3 B. Braun (Germany) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.1.4 B. Braun (Germany) Product Portfolio 6.1.5 B. Braun (Germany) Recent Developments/Updates 6.2 C. R. Bard (US) 6.2.1 C. R. Bard (US) Corporation Information 6.2.2 C. R. Bard (US) Description and Business Overview 6.2.3 C. R. Bard (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.2.4 C. R. Bard (US) Product Portfolio 6.2.5 C. R. Bard (US) Recent Developments/Updates 6.3 Cardinal Health (US) 6.3.1 Cardinal Health (US) Corporation Information 6.3.2 Cardinal Health (US) Description and Business Overview 6.3.3 Cardinal Health (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Cardinal Health (US) Product Portfolio 6.3.5 Cardinal Health (US) Recent Developments/Updates 6.4 Cook Medical (US) 6.4.1 Cook Medical (US) Corporation Information 6.4.2 Cook Medical (US) Description and Business Overview 6.4.3 Cook Medical (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Cook Medical (US) Product Portfolio 6.4.5 Cook Medical (US) Recent Developments/Updates 6.5 Endologix (US) 6.5.1 Endologix (US) Corporation Information 6.5.2 Endologix (US) Description and Business Overview 6.5.3 Endologix (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Endologix (US) Product Portfolio 6.5.5 Endologix (US) Recent Developments/Updates 6.6 LeMaitre Vascular (US) 6.6.1 LeMaitre Vascular (US) Corporation Information 6.6.2 LeMaitre Vascular (US) Description and Business Overview 6.6.3 LeMaitre Vascular (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.6.4 LeMaitre Vascular (US) Product Portfolio 6.6.5 LeMaitre Vascular (US) Recent Developments/Updates 6.7 Medtronic (Ireland) 6.6.1 Medtronic (Ireland) Corporation Information 6.6.2 Medtronic (Ireland) Description and Business Overview 6.6.3 Medtronic (Ireland) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Medtronic (Ireland) Product Portfolio 6.7.5 Medtronic (Ireland) Recent Developments/Updates 6.8 Maquet (Germany) 6.8.1 Maquet (Germany) Corporation Information 6.8.2 Maquet (Germany) Description and Business Overview 6.8.3 Maquet (Germany) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Maquet (Germany) Product Portfolio 6.8.5 Maquet (Germany) Recent Developments/Updates 6.9 Terumo (Japan) 6.9.1 Terumo (Japan) Corporation Information 6.9.2 Terumo (Japan) Description and Business Overview 6.9.3 Terumo (Japan) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Terumo (Japan) Product Portfolio 6.9.5 Terumo (Japan) Recent Developments/Updates 6.10 Gore Medical (US) 6.10.1 Gore Medical (US) Corporation Information 6.10.2 Gore Medical (US) Description and Business Overview 6.10.3 Gore Medical (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Gore Medical (US) Product Portfolio 6.10.5 Gore Medical (US) Recent Developments/Updates 7 Vascular Biosynthetic Grafts Manufacturing Cost Analysis 7.1 Vascular Biosynthetic Grafts Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Vascular Biosynthetic Grafts 7.4 Vascular Biosynthetic Grafts Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Vascular Biosynthetic Grafts Distributors List 8.3 Vascular Biosynthetic Grafts Customers 9 Vascular Biosynthetic Grafts Market Dynamics 9.1 Vascular Biosynthetic Grafts Industry Trends 9.2 Vascular Biosynthetic Grafts Growth Drivers 9.3 Vascular Biosynthetic Grafts Market Challenges 9.4 Vascular Biosynthetic Grafts Market Restraints 10 Global Market Forecast 10.1 Vascular Biosynthetic Grafts Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Vascular Biosynthetic Grafts by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Vascular Biosynthetic Grafts by Type (2022-2027) 10.2 Vascular Biosynthetic Grafts Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Vascular Biosynthetic Grafts by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Vascular Biosynthetic Grafts by Application (2022-2027) 10.3 Vascular Biosynthetic Grafts Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Vascular Biosynthetic Grafts by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Vascular Biosynthetic Grafts by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Vascular Biosynthetic Grafts Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Vascular Biosynthetic Grafts Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Vascular Biosynthetic Grafts Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Vascular Biosynthetic Grafts Covered in This Study Table 5. Global Vascular Biosynthetic Grafts Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Vascular Biosynthetic Grafts Sales Share by Manufacturers (2016-2021) Table 7. Global Vascular Biosynthetic Grafts Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Vascular Biosynthetic Grafts Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Vascular Biosynthetic Grafts Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Vascular Biosynthetic Grafts Manufacturing Sites and Area Served Table 11. Manufacturers Vascular Biosynthetic Grafts Product Type Table 12. Global Vascular Biosynthetic Grafts Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Vascular Biosynthetic Grafts by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vascular Biosynthetic Grafts as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Vascular Biosynthetic Grafts Sales by Region (2016-2021) & (K Units) Table 16. Global Vascular Biosynthetic Grafts Sales Market Share by Region (2016-2021) Table 17. Global Vascular Biosynthetic Grafts Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Vascular Biosynthetic Grafts Sales by Country (2016-2021) & (K Units) Table 19. North America Vascular Biosynthetic Grafts Sales Market Share by Country (2016-2021) Table 20. North America Vascular Biosynthetic Grafts Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Vascular Biosynthetic Grafts Revenue Market Share by Country (2016-2021) Table 22. Europe Vascular Biosynthetic Grafts Sales by Country (2016-2021) & (K Units) Table 23. Europe Vascular Biosynthetic Grafts Sales Market Share by Country (2016-2021) Table 24. Europe Vascular Biosynthetic Grafts Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Vascular Biosynthetic Grafts Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Vascular Biosynthetic Grafts Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Vascular Biosynthetic Grafts Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Vascular Biosynthetic Grafts Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Vascular Biosynthetic Grafts Revenue Market Share by Region (2016-2021) Table 30. Latin America Vascular Biosynthetic Grafts Sales by Country (2016-2021) & (K Units) Table 31. Latin America Vascular Biosynthetic Grafts Sales Market Share by Country (2016-2021) Table 32. Latin America Vascular Biosynthetic Grafts Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Vascular Biosynthetic Grafts Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Vascular Biosynthetic Grafts Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Vascular Biosynthetic Grafts Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Vascular Biosynthetic Grafts Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Vascular Biosynthetic Grafts Revenue Market Share by Country (2016-2021) Table 38. Global Vascular Biosynthetic Grafts Sales (K Units) by Type (2016-2021) Table 39. Global Vascular Biosynthetic Grafts Sales Market Share by Type (2016-2021) Table 40. Global Vascular Biosynthetic Grafts Revenue (Million US$) by Type (2016-2021) Table 41. Global Vascular Biosynthetic Grafts Revenue Share by Type (2016-2021) Table 42. Global Vascular Biosynthetic Grafts Price (USD/Unit) by Type (2016-2021) Table 43. Global Vascular Biosynthetic Grafts Sales (K Units) by Application (2016-2021) Table 44. Global Vascular Biosynthetic Grafts Sales Market Share by Application (2016-2021) Table 45. Global Vascular Biosynthetic Grafts Revenue (Million US$) by Application (2016-2021) Table 46. Global Vascular Biosynthetic Grafts Revenue Share by Application (2016-2021) Table 47. Global Vascular Biosynthetic Grafts Price (USD/Unit) by Application (2016-2021) Table 48. B. Braun (Germany) Corporation Information Table 49. B. Braun (Germany) Description and Business Overview Table 50. B. Braun (Germany) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. B. Braun (Germany) Vascular Biosynthetic Grafts Product Table 52. B. Braun (Germany) Recent Developments/Updates Table 53. C. R. Bard (US) Corporation Information Table 54. C. R. Bard (US) Description and Business Overview Table 55. C. R. Bard (US) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. C. R. Bard (US) Vascular Biosynthetic Grafts Product Table 57. C. R. Bard (US) Recent Developments/Updates Table 58. Cardinal Health (US) Corporation Information Table 59. Cardinal Health (US) Description and Business Overview Table 60. Cardinal Health (US) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Cardinal Health (US) Vascular Biosynthetic Grafts Product Table 62. Cardinal Health (US) Recent Developments/Updates Table 63. Cook Medical (US) Corporation Information Table 64. Cook Medical (US) Description and Business Overview Table 65. Cook Medical (US) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Cook Medical (US) Vascular Biosynthetic Grafts Product Table 67. Cook Medical (US) Recent Developments/Updates Table 68. Endologix (US) Corporation Information Table 69. Endologix (US) Description and Business Overview Table 70. Endologix (US) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Endologix (US) Vascular Biosynthetic Grafts Product Table 72. Endologix (US) Recent Developments/Updates Table 73. LeMaitre Vascular (US) Corporation Information Table 74. LeMaitre Vascular (US) Description and Business Overview Table 75. LeMaitre Vascular (US) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 76. LeMaitre Vascular (US) Vascular Biosynthetic Grafts Product Table 77. LeMaitre Vascular (US) Recent Developments/Updates Table 78. Medtronic (Ireland) Corporation Information Table 79. Medtronic (Ireland) Description and Business Overview Table 80. Medtronic (Ireland) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 81. Medtronic (Ireland) Vascular Biosynthetic Grafts Product Table 82. Medtronic (Ireland) Recent Developments/Updates Table 83. Maquet (Germany) Corporation Information Table 84. Maquet (Germany) Description and Business Overview Table 85. Maquet (Germany) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 86. Maquet (Germany) Vascular Biosynthetic Grafts Product Table 87. Maquet (Germany) Recent Developments/Updates Table 88. Terumo (Japan) Corporation Information Table 89. Terumo (Japan) Description and Business Overview Table 90. Terumo (Japan) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 91. Terumo (Japan) Vascular Biosynthetic Grafts Product Table 92. Terumo (Japan) Recent Developments/Updates Table 93. Gore Medical (US) Corporation Information Table 94. Gore Medical (US) Description and Business Overview Table 95. Gore Medical (US) Vascular Biosynthetic Grafts Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 96. Gore Medical (US) Vascular Biosynthetic Grafts Product Table 97. Gore Medical (US) Recent Developments/Updates Table 98. Production Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Vascular Biosynthetic Grafts Distributors List Table 101. Vascular Biosynthetic Grafts Customers List Table 102. Vascular Biosynthetic Grafts Market Trends Table 103. Vascular Biosynthetic Grafts Growth Drivers Table 104. Vascular Biosynthetic Grafts Market Restraints Table 105. Global Vascular Biosynthetic Grafts Sales Forecast by Type (2022-2027) & (K Units) Table 106. Global Vascular Biosynthetic Grafts Sales Market Share Forecast by Type (2022-2027) Table 107. Global Vascular Biosynthetic Grafts Revenue Forecast by Type (2022-2027) & (US$ Million) Table 108. Global Vascular Biosynthetic Grafts Revenue Market Share Forecast by Type (2022-2027) Table 109. Global Vascular Biosynthetic Grafts Sales Forecast by Application (2022-2027) & (K Units) Table 110. Global Vascular Biosynthetic Grafts Sales Market Share Forecast by Application (2022-2027) Table 111. Global Vascular Biosynthetic Grafts Revenue Forecast by Application (2022-2027) & (US$ Million) Table 112. Global Vascular Biosynthetic Grafts Revenue Market Share Forecast by Application (2022-2027) Table 113. Global Vascular Biosynthetic Grafts Sales Forecast by Region (2022-2027) & (K Units) Table 114. Global Vascular Biosynthetic Grafts Sales Market Share Forecast by Region (2022-2027) Table 115. Global Vascular Biosynthetic Grafts Revenue Forecast by Region (2022-2027) & (US$ Million) Table 116. Global Vascular Biosynthetic Grafts Revenue Market Share Forecast by Region (2022-2027) Table 117. Research Programs/Design for This Report Table 118. Key Data Information from Secondary Sources Table 119. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Vascular Biosynthetic Grafts Figure 2. Global Vascular Biosynthetic Grafts Market Share by Type in 2020 & 2027 Figure 3. Endovascular Aneurysm Repair Product Picture Figure 4. Peripheral Vascular Product Picture Figure 5. Hemodialysis Access Product Picture Figure 6. Global Vascular Biosynthetic Grafts Market Share by Application in 2020 & 2027 Figure 7. Hospitals Figure 8. Ambulatory Surgical Centers Figure 9. Global Vascular Biosynthetic Grafts Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Vascular Biosynthetic Grafts Market Size 2016-2027 (US$ Million) Figure 11. Global Vascular Biosynthetic Grafts Sales 2016-2027 (K Units) Figure 12. Global Vascular Biosynthetic Grafts Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Vascular Biosynthetic Grafts Sales Share by Manufacturers in 2020 Figure 14. Global Vascular Biosynthetic Grafts Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Vascular Biosynthetic Grafts Players: Market Share by Revenue in 2020 Figure 16. Vascular Biosynthetic Grafts Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Vascular Biosynthetic Grafts Sales Market Share by Region (2016-2021) Figure 18. Global Vascular Biosynthetic Grafts Sales Market Share by Region in 2020 Figure 19. Global Vascular Biosynthetic Grafts Revenue Market Share by Region (2016-2021) Figure 20. Global Vascular Biosynthetic Grafts Revenue Market Share by Region in 2020 Figure 21. U.S. Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Vascular Biosynthetic Grafts Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Vascular Biosynthetic Grafts by Type (2016-2021) Figure 46. Sales Market Share of Vascular Biosynthetic Grafts by Application (2016-2021) Figure 47. Sales Market Share of Vascular Biosynthetic Grafts by Application in 2020 Figure 48. Revenue Share of Vascular Biosynthetic Grafts by Application (2016-2021) Figure 49. Revenue Share of Vascular Biosynthetic Grafts by Application in 2020 Figure 50. Manufacturing Cost Structure of Vascular Biosynthetic Grafts Figure 51. Manufacturing Process Analysis of Vascular Biosynthetic Grafts Figure 52. Vascular Biosynthetic Grafts Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

B. Braun (Germany) C. R. Bard (US) Cardinal Health (US) Cook Medical (US) Endologix (US) LeMaitre Vascular (US) Medtronic (Ireland) Maquet (Germany) Terumo (Japan) Gore Medical (US)